Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher P Filson

Showing results (61-70 of 121) with videos related to

Pageof 13
Sort By:
Urology Practice|April 27, 2023
Prolonged Opioid Use Following Bladder Tumor Resection for Opioid-naïve PatientsBenjamin Croll, Dattatraya Patil, Misaki Mason, et al.
The Journal of Urology|February 13, 2014
Variation in use of active surveillance among men undergoing expectant treatment for early stage prostate cancerChristopher P Filson, Florian R Schroeck, Zaojun Ye, et al.
Urology|August 7, 2017
Comparative Cost Analysis: Teleurology vs Conventional Face-to-Face ClinicsVitaly Zholudev, Ilan J Safir, Mark N Painter, et al.
Urologic Oncology|December 14, 2016
Health status and use of partial nephrectomy in older adults with early-stage kidney cancerHung-Jui Tan, Timothy J Daskivich, Joseph D Shirk, et al.
Urology|April 22, 2018
Adoption of Prebiopsy Magnetic Resonance Imaging for Men Undergoing Prostate Biopsy in the United StatesWen Liu, Dattatraya Patil, David H Howard, et al.
The British Journal of Radiology|January 9, 2018
In-bore MRI-guided biopsy: can it optimize the need for periodic biopsies in prostate cancer patients undergoing active surveillance? A pilot test-retest reliability studyKareem K Elfatairy, Christopher P Filson, Martin G Sanda, et al.
Urologic Oncology|December 6, 2018
Impact of prebiopsy magnetic resonance imaging of the prostate on cancer detection and treatment patternsWen Liu, Dattatraya Patil, David H Howard, et al.
Cancer Medicine|November 13, 2021
Longitudinal impact of bladder cancer diagnosis on common psychiatric disordersIan J Cooke, Dattatraya Patil, Katherine Bobrek, et al.
Cancer|June 17, 2023
The cost burden of metastatic prostate cancer in the US populations covered by employer-sponsored health insuranceMichal Horný, K Robin Yabroff, Christopher P Filson, et al.
Urologic Oncology|May 12, 2025
Patterns of telehealth use in newly diagnosed prostate cancer patientsNicholas W Eyrich, Dattatraya Patil, Siddharth Marthi, et al.
Pageof 13

Showing results (61-70 of 121) with videos related to

Sort By:
Pageof 13
Urology Practice|April 27, 2023
Prolonged Opioid Use Following Bladder Tumor Resection for Opioid-naïve PatientsBenjamin Croll, Dattatraya Patil, Misaki Mason, et al.
The Journal of Urology|February 13, 2014
Variation in use of active surveillance among men undergoing expectant treatment for early stage prostate cancerChristopher P Filson, Florian R Schroeck, Zaojun Ye, et al.
Urology|August 7, 2017
Comparative Cost Analysis: Teleurology vs Conventional Face-to-Face ClinicsVitaly Zholudev, Ilan J Safir, Mark N Painter, et al.
Urologic Oncology|December 14, 2016
Health status and use of partial nephrectomy in older adults with early-stage kidney cancerHung-Jui Tan, Timothy J Daskivich, Joseph D Shirk, et al.
Urology|April 22, 2018
Adoption of Prebiopsy Magnetic Resonance Imaging for Men Undergoing Prostate Biopsy in the United StatesWen Liu, Dattatraya Patil, David H Howard, et al.
The British Journal of Radiology|January 9, 2018
In-bore MRI-guided biopsy: can it optimize the need for periodic biopsies in prostate cancer patients undergoing active surveillance? A pilot test-retest reliability studyKareem K Elfatairy, Christopher P Filson, Martin G Sanda, et al.
Urologic Oncology|December 6, 2018
Impact of prebiopsy magnetic resonance imaging of the prostate on cancer detection and treatment patternsWen Liu, Dattatraya Patil, David H Howard, et al.
Cancer Medicine|November 13, 2021
Longitudinal impact of bladder cancer diagnosis on common psychiatric disordersIan J Cooke, Dattatraya Patil, Katherine Bobrek, et al.
Cancer|June 17, 2023
The cost burden of metastatic prostate cancer in the US populations covered by employer-sponsored health insuranceMichal Horný, K Robin Yabroff, Christopher P Filson, et al.
Urologic Oncology|May 12, 2025
Patterns of telehealth use in newly diagnosed prostate cancer patientsNicholas W Eyrich, Dattatraya Patil, Siddharth Marthi, et al.
Pageof 13